Pipeline & Technology

Our Pipeline

Cara Therapeutics Drug Development

Drug Indication Preclinical Phase I Phase II Phase III Commercialization
Pain
Pain IV CR845 Post-Op Pain
Oral CR845 Chronic Pain
Oral CR701 Chronic Pain
Pruritus
Pruritus IV CR845 Pruritus CKD-HD
Oral CR845 Pruritus